Mink Therapeutics Inc

General ticker "INKT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $25.5M

Mink Therapeutics Inc does not follow the US Stock Market performance with the rate: -32.6%.

Estimated limits based on current volatility of 7.4%: low 0.47$, high 0.54$

Factors to consider:

  • Current price 12.0% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.56$, 1.70$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.55$, 1.65$]

Financial Metrics affecting the INKT estimates:

  • Negative: Non-GAAP EPS, $ of -0.66 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -31.06 <= 2.35
  • Negative: negative Net income
  • Positive: Interest expense per share, $ of 0 <= 0

Similar symbols

Short-term INKT quotes

Long-term INKT plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $2,704.74MM $0.00MM
Operating Expenses $28.36MM $2,735.69MM $22.92MM
Operating Income $-28.36MM $-30.95MM $-22.92MM
Non-Operating Income $-1.85MM $2.96MM $0.46MM
Interest Expense $2.43MM $0.25MM $0.00MM
R&D Expense $13.97MM $23.12MM $15.49MM
Income(Loss) $-30.21MM $-27.99MM $-22.46MM
Taxes $-7.10MM $-3.21MM $0.00MM
Profit(Loss) $-23.11MM $-24.78MM $-22.46MM
Stockholders Equity $23.78MM $-0.40MM $-18.06MM
Inventory $0.00MM $0.00MM $0.00MM
Assets $40.24MM $21.47MM $4.55MM
Operating Cash Flow $-12.83MM $-18.87MM $-15.76MM
Capital expenditure $0.25MM $0.25MM $0.07MM
Investing Cash Flow $-0.25MM $-0.25MM $-0.07MM
Financing Cash Flow $49.26MM $-0.16MM $-0.41MM
Earnings Per Share* $-0.69 $-0.74 $-0.65

* EPS are Split Adjusted, recent splits may be reflected with a delay.